Related by context. All words. (Click for frequent words.) 74 tolerability profiles 72 tolerability 71 pharmacokinetic profile 71 pharmacokinetic properties 71 analgesic efficacy 70 pharmacodynamic properties 70 tolerability profile 69 pharmacokinetics pharmacodynamics 69 pharmacokinetics PK 69 antiviral efficacy 69 efficacy tolerability 68 pharmacodynamics 68 pharmacokinetic characteristics 68 dosing regimens 68 pharmacokinetic parameters 68 CaPre TM 68 oral bioavailability 68 pharmacodynamics PD 67 biodistribution 67 pharmacokinetics 67 dosage regimens 67 pharmacodynamic PD 67 mesalamine granules 66 pharmacokinetic 66 pharmacodynamic profile 66 antitumor efficacy 66 cannabinor 66 teriflunomide 66 antitumor activity 66 oral rivaroxaban 66 galiximab 66 favorable pharmacokinetic profile 66 dosing frequency 65 FOSRENOL ® 65 erythropoietic 65 fluticasone furoate 65 oral dosing 65 dose proportionality 65 pharmacokinetic PK profile 65 pharmacodynamic parameters 65 PDE4 inhibitors 65 capsule formulation 65 mecamylamine 65 efficacy 64 reactogenicity 64 prucalopride 64 demonstrated antitumor activity 64 antiviral potency 64 pharmacodynamic 64 potency selectivity 64 Xanafide 64 plasma kallikrein inhibitor 64 posaconazole 64 receptor inhibitor 64 preclinical efficacy 64 CANCIDAS 64 anticancer activity 64 oral prodrug 64 pharmacokinetic PK 64 desvenlafaxine succinate 64 safety tolerability pharmacokinetic 64 vidofludimus 64 systemically administered 64 administered subcutaneously 64 fosbretabulin 64 Edarbi 64 pharmacokinetic PK study 64 Omacetaxine mepesuccinate 64 subcutaneous dosing 63 coadministration 63 animal xenograft models 63 LAB CGRP 63 non selective NSAIDs 63 LT NS# 63 anti leukemic 63 dose regimens 63 deferiprone 63 liposomal formulation 63 pharmacodynamic effects 63 Interferon alpha 63 Traficet EN 63 inhaled iloprost 63 sorafenib Nexavar 63 clomipramine 63 MYCAMINE 63 oral dosing regimen 63 subcutaneous SC 63 ritonavir boosted 63 vivo potency 63 trospium 63 antithrombotic 63 active comparator 63 immunogenicity 63 LEP ETU 63 NPH insulin 63 Perforomist ™ Inhalation Solution 63 CorVue ™ 63 CIMZIA ™ 63 GLP1 agonist 63 renal toxicity 63 PSN# [002] 63 tecarfarin 63 ENMD # 63 pharmacokinetic equivalence 63 Aclidinium 63 combinability 63 dosing regimen 63 tigecycline 63 pharmacokinetic pharmacodynamic 63 rHuPH# 63 ganetespib 62 clevidipine 62 demonstrated clinically meaningful 62 #mg dose [001] 62 immune modulating 62 MoxDuo 62 Anticalins ® 62 Tarceva TM 62 GAMMAGARD 62 intravesical 62 favorable tolerability 62 REMINYL ® 62 DexaSite 62 adenosine injection 62 chlorambucil 62 metabolic parameters 62 selective modulator 62 Panzem R NCD 62 Azedra 62 cariprazine 62 mapatumumab 62 convenient dosing regimens 62 oral diclofenac 62 retapamulin 62 INCB# [001] 62 diabetic neuropathic pain 62 IFN beta 62 antitumor effect 62 docetaxel Taxotere ® 62 SCH # 62 caspofungin 62 platelet inhibitor 62 urate lowering 62 azelastine 62 Dabigatran etexilate 62 APTIVUS r 62 Losartan 62 MAGE A3 ASCI 62 pharmacokinetic studies 62 mTOR inhibitors 62 INVEGA ® 62 davunetide intranasal AL 62 dosing schedules 62 riociguat 62 EGFR antibodies 62 pioglitazone HCl 62 Archexin 62 tolerability pharmacokinetics 62 pharmacodynamic markers 62 SPIRIVA HandiHaler 62 tolterodine 62 topical formulations 62 pyridostigmine 62 factor Xa inhibitor 62 lisdexamfetamine dimesylate 62 candesartan cilexetil 62 systemic absorption 62 liposome formulation 62 PRT# 62 injectable formulations 62 edoxaban 62 active moiety 62 VAPRISOL 62 CYT# 62 intravenous dosing 62 HIF PH inhibitors 62 QTc prolongation 62 ketorolac 62 idraparinux 62 abacavir lamivudine 62 myopathy rhabdomyolysis 62 pain palliation 62 BAY #-# 61 Seliciclib 61 mg kg BID 61 albiglutide 61 6mg 61 mu opioid receptor antagonist 61 safety tolerability pharmacokinetics 61 maximally tolerated dose 61 AZILECT R 61 JAK inhibitor 61 tasimelteon 61 SERMs 61 achieved statistical significance 61 Hyphanox 61 CCX# 61 radezolid 61 pertuzumab 61 anti angiogenic agents 61 Ophena TM 61 opioid receptor antagonist 61 safety tolerability 61 favorable pharmacokinetic 61 pharmacodynamic profiles 61 Bezielle 61 acitretin 61 Pharmacokinetic parameters 61 amifostine 61 MAP# 61 glycopyrrolate 61 NEUGENE antisense 61 isoproterenol 61 antidiabetic drugs 61 Darinaparsin 61 anti amnesic 61 miconazole 61 Primary endpoints 61 NEVO ™ 61 LCP Tacro TM 61 bovine thrombin 61 olmesartan 61 uric acid lowering 61 visilizumab 61 MGd 61 erlotinib Tarceva ® 61 antiviral activity 61 liposomal amphotericin B 61 preclinically 61 Panzem R 61 adipiplon 61 Zoraxel TM 61 bronchodilation 61 torezolid phosphate 61 interferon alfa 2b 61 sitaxsentan 61 GLYX 61 insulin lispro 61 Zoraxel 61 DAVANAT 61 nucleoside analog 61 KAPIDEX 61 alvimopan 61 glatiramer acetate 61 #mg doses [002] 61 MoxDuo IR 61 alicaforsen enema 61 latanoprost 61 S/GSK# 61 subcutaneously administered 61 dose cohorts 61 timolol 61 MGN# 61 ESBA# 61 APTIVUS 61 oxymorphone ER 61 AST ALT 61 potent antiviral 61 exendin 4 61 PDE4 inhibitor 61 ALB # 61 oral gallium 61 peripherally acting 61 Perforomist Inhalation Solution 61 USL# 61 subcutaneously injected 61 Fulvestrant 61 #HT#A 61 varespladib 61 Tolerability 61 noninferiority 61 DACH platinum 61 overlapping toxicities 61 latrepirdine 61 XmAb# 61 antiangiogenic activity 61 Dasatinib 61 β blockers 61 Intravail R 61 Carvedilol 61 histamine dihydrochloride 61 LY# [003] 61 xanthine oxidase inhibitor 61 antigenicity 61 piroxicam 61 partial agonist 61 Oral NKTR 61 vapreotide acetate 61 Androxal TM 61 paricalcitol 61 intravesical instillation 61 Sym# 61 ascending doses 61 RoACTEMRA 61 zonisamide SR 61 octreotide acetate 61 indibulin 60 Teriflunomide 60 1mg 2mg 60 CIMZIA TM certolizumab pegol 60 topical diclofenac 60 TPI ASM8 60 gadobutrol 60 granisetron 60 NP2 Enkephalin 60 lipid lowering therapies 60 EOquin TM 60 metaglidasen 60 insulin detemir 60 Phase 1b trial 60 BYETTA exenatide injection 60 EMBEDA ™ 60 cardiac toxicity 60 HCV protease inhibitors 60 gemcitabine carboplatin 60 multitargeted 60 RLY# 60 trastuzumab emtansine T DM1 60 fluvastatin 60 calcineurin inhibitors 60 propafenone 60 baminercept 60 intermittent dosing 60 bioavailability 60 pharmacokinetic interactions 60 HGS# 60 pharmacodynamic endpoints 60 zoledronate 60 Inhalation Solution 60 Dual Opioid 60 nebulized formoterol fumarate 60 Pharmacokinetics PK 60 iodixanol 60 ancrod 60 ocular formulation 60 zaleplon 60 beta2 agonist 60 pramlintide metreleptin combination 60 6R BH4 60 azacitidine 60 Chemophase 60 tanespimycin 60 intracellular uptake 60 Tekturna HCT 60 Novolimus 60 thalidomide Thalomid 60 antidepressant efficacy 60 IFN α 60 leflunomide 60 NeuroSTAT ® 60 XOPENEX Inhalation Solution 60 bosentan 60 ADAGIO study 60 sipuleucel T 60 Visipaque 60 secondary efficacy endpoints 60 Diovan HCT 60 mycophenolate mofetil 60 Meta analyzes 60 liposomal doxorubicin 60 evaluating tivozanib 60 ATACAND 60 sublingual formulation 60 docetaxel Taxotere 60 bromfenac 60 sitagliptin 60 Proquin XR 60 dosage regimen 60 irbesartan 60 salmeterol fluticasone 60 investigational humanized monoclonal antibody 60 micafungin 60 PROCHYMAL 60 cefepime 60 ulimorelin 60 TREDAPTIVE 60 sulphonylureas 60 Pegasys ® 60 teduglutide 60 enzastaurin 60 Vidaza azacitidine 60 gemifloxacin 60 mGluR5 NAM 60 Tasimelteon 60 antiarrhythmic drug 60 Anticalins R 60 alfuzosin 60 tobramycin 60 selegiline 60 delafloxacin 60 aclidinium 60 placebo controlled clinical 60 neuroprotective properties 60 Amphinex ® 60 AzaSite Plus 60 Tolvaptan 60 Alocrest 60 plasma pharmacokinetics 60 BeneFIX 60 Pharmacokinetic 60 Protelos 60 dimeglumine 60 IV bisphosphonates 60 orally dosed 60 therapeutic regimens 60 amphotericin B 60 apremilast 60 SYNERGY Stent 60 tacrolimus ointment 60 ruxolitinib 60 antimuscarinic 60 divalproex sodium 60 Aplidin 60 TG# [003] 60 oral FTY# 60 BMS# 60 lenalidomide dexamethasone 60 HMG CoA reductase inhibitors 60 Fondaparinux 60 glycosylated hemoglobin levels 60 Secondary endpoints 60 linear pharmacokinetics 60 Afatinib 60 Neulasta ® 60 Carfilzomib 60 antitumor effects 60 chemotherapeutic drug 60 titrated glipizide 60 ALGRX 60 rNAPc2 60 novel VDA molecule 60 L PPDS 60 tapentadol ER 60 pomalidomide 60 mercaptopurine 60 topical formulation 60 hemostatic efficacy 60 piperacillin tazobactam 60 novel histone deacetylase 60 echinocandin 60 ARIKACE 60 Elitek 60 Hematologic toxicity 60 Cleviprex TM clevidipine 60 orally administered inhibitor 60 systemic immunosuppressive drugs 60 pentoxifylline 60 insulin sensitizing 60 Apoptone 60 KRAS status 60 DU #b 60 sitagliptin Januvia 60 zileuton 60 QT QTc 60 Zysolin TM 60 NMDA antagonists 60 antiarrhythmic 60 calcipotriene 60 MEK inhibitors 60 hypericin 60 nonclinical studies 60 vorinostat 60 PS# [001] 60 Vidofludimus 60 Phase 1b clinical trials 60 Aeroquin 60 factor Xa 60 alefacept 60 INCB# [003] 60 gemcitabine cisplatin 60 p# biomarkers 60 #mg dose [003] 59 Fidaxomicin 59 sorafenib tablets 59 antiemetics 59 macrolide antibiotic 59 Etoposide 59 BAL# [002] 59 Capesaris 59 MIRCERA 59 cytoprotective 59 ACTEMRA TM 59 tumorigenicity 59 relapsed MM 59 miconazole Lauriad ® 59 solithromycin 59 oral antiviral 59 Preclinical studies suggest 59 Phase #b/#a trial 59 Secondary endpoints include 59 intravenously administered 59 depsipeptide 59 Q#IR 59 eplerenone 59 tolvaptan 59 #beta estradiol 59 lanthanum carbonate 59 TriRima 59 HGS ETR2 59 tezampanel 59 PEGPH# 59 oral deforolimus 59 Keppra XR 59 fluoroquinolone antibiotic 59 raltegravir 59 budesonide formoterol 59 Eligen R B# 59 urocortin 2 59 Cloretazine R VNP#M 59 Focalin XR 59 RG# [001] 59 plasma triglycerides 59 idarubicin 59 EXPAREL ™ 59 Onconase 59 Moxifloxacin 59 parathyroid hormone PTH 59 TELINTRA 59 bronchodilatory 59 DCCR 59 CIMZIA TM 59 PREZISTA r 59 dose proportional pharmacokinetics 59 nucleoside analogs 59 TAXUS VI 59 injectable diclofenac 59 paclitaxel Taxol ® 59 aripiprazole Abilify 59 Virulizin ® 59 ZYBRESTAT fosbretabulin 59 non steroidal 59 dexamethasone Decadron 59 telcagepant 59 melphalan prednisone 59 tylosin 59 mg doses 59 mealtime insulin 59 quetiapine Seroquel 59 CINQUIL 59 intravenous cyclophosphamide 59 IMC A# 59 weekly subcutaneous injections 59 menadione 59 EFAPROXYN 59 trastuzumab Herceptin ® 59 INCB# [002] 59 itraconazole 59 GAMMAGARD LIQUID 59 GHRH 59 MTP inhibitor 59 pegylated liposomal doxorubicin 59 DDP# 59 Neurodex 59 Interferon beta 1a 59 GRALISE 59 YONDELIS 59 tizanidine 59 optimal dosing 59 exploratory endpoints 59 Pazopanib 59 Targretin 59 GSK# [001] 59 orally inhaled 59 Pemetrexed 59 panitumumab Vectibix 59 rhGH 59 imipenem 59 fenofibric acid 59 pimecrolimus 59 S1P antibody 59 EDARBI 59 microtubule inhibitor 59 Akt activation 59 EOquin 59 multidose 59 CTAP# Capsules 59 vascular disrupting agents 59 Axid 59 bexarotene 59 SGS# 59 beclomethasone dipropionate 59 GFT# 59 ORENCIA R 59 ULORIC 59 topical gel formulation 59 hypoxia activated prodrug 59 serotonin norepinephrine reuptake inhibitor 59 ADP receptor antagonist 59 vildagliptin 59 Dapagliflozin 59 effector function 59 casopitant 59 r hGH 59 Amrubicin 59 Anidulafungin 59 HGS ETR1 mapatumumab 59 nicardipine 59 immunomodulatory effects 59 Ereska 59 cystinosis patients 59 tadalafil Cialis 59 milatuzumab 59 Anturol TM 59 SUTENT ® 59 PXD# 59 escitalopram Lexapro 59 lipid parameters 59 AZILECT 59 oral renin inhibitor 59 ZOLINZA 59 RISPERDAL ® 59 non selective NMDA 59 tolterodine ER 59 ACIPHEX 59 Aflibercept 59 histone deacetylase inhibitor 59 immunomodulatory therapy 59 treprostinil 59 oral ridaforolimus 59 ziprasidone 59 FOLPI 59 anti arrhythmic 59 raloxifene Evista 59 AKT inhibitor 59 acamprosate 59 ACTOS ® 59 UPLYSO 59 parecoxib 59 ritonavir boosted protease inhibitor 59 TLK# 59 daunorubicin 59 glucose lowering 59 sunitinib Sutent ® 59 hypomagnesemia 59 antifibrinolytic 59 intranasal formulation 59 Enhanze Technology 59 headache nasopharyngitis 59 Neuradiab 59 pitavastatin 59 TO AVOID PREGNANCY WHILE 59 vitro cytotoxicity 59 long acting muscarinic 59 K ras mutations 59 Mitoxantrone 59 TEMODAL 59 ritonavir boosting 59 oxcarbazepine 59 betamethasone dipropionate 59 efficacy endpoints 59 forodesine 59 subcutaneous formulation 59 capsules USP 59 axitinib 59 oral antidiabetic 59 vinorelbine 59 elacytarabine 59 azilsartan medoxomil 59 aspirin clopidogrel 59 febuxostat 59 PF # [001] 59 mg/m2 cohort 59 TH# [003] 59 inhibitor RG# 59 Linagliptin 59 Triolex 59 indomethacin 59 immune modulatory 59 Durezol 59 gastrointestinal motility 59 liposome injection 59 atazanavir ritonavir 59 CRLX# 59 fumagillin nanoparticles 59 PPAR gamma agonist 59 LIALDA 59 busulfan 59 Taxotere chemotherapy 59 rFIXFc 59 lapatinib Tykerb 59 cinacalcet 59 Daptomycin 59 nephrotoxicity 59 concurrent chemoradiation 59 oral formulation 59 fosamprenavir 59 cobalamin 59 nitazoxanide 59 5alpha reductase 59 eprotirome 59 serum concentrations 59 Exelixis compounds 59 ginkgo extract 59 terfenadine 59 antidepressants SSRIs 59 mg dose 59 antiepileptics 59 velafermin 59 #mg dose [002] 59 dose regimen 59 Vaxfectin R 59 topiramate Topamax 59 BENICAR HCT 59 fulvestrant 59 levalbuterol 59 oxazolidinone 59 octreotide LAR 59 pegylated interferon alfa 59 calcitonin 59 inhaled formulation 59 placebo controlled clinical trials 59 placebo controlled studies 59 somatostatin analogue 58 cholestyramine 58 mcg dose 58 gemcitabine Gemzar 58 double blinded placebo 58 Belerofon 58 convenient dosing regimen 58 alpha blocker 58 Quetiapine 58 postprandial glycemia 58 Xeloda ® 58 Rifampin 58 PegIFN 58 Lubiprostone 58 Ziprasidone 58 direct thrombin inhibitors 58 beta adrenergic 58 hepatotoxic 58 Targretin capsules 58 tenofovir emtricitabine 58 novel prodrug 58 docetaxel chemotherapy 58 JANUVIA 58 AAG geldanamycin analog 58 decitabine 58 Pharmacokinetic studies 58 esomeprazole 58 timolol maleate 58 Taxol ® 58 omeprazole Prilosec 58 serum cortisol 58 pegylated 58 MEVACOR 58 oxaliplatin Eloxatin 58 ZYVOX 58 Vilazodone 58 topoisomerase II inhibitor 58 proton pump inhibitor PPI 58 Warfarin Coumadin 58 Zoloft sertraline 58 tamoxifen Nolvadex ® 58 Mg Uk 58 flecainide 58 ORMD 58 prospectively defined 58 intravenous formulations 58 rosuvastatin Crestor 58 Tyrima 58 deferoxamine 58 alvespimycin 58 dose dependently 58 lomitapide 58 everolimus eluting stents 58 NOXAFIL Oral Suspension 58 eszopiclone 58 prostaglandin E1 58 statin simvastatin 58 synthase TS 58 budesonide foam 58 selective adenosine 58 eculizumab therapy 58 Ceplene/IL-2 58 zolmitriptan 58 wilate ® 58 Capecitabine 58 adecatumumab 58 Mg Usa 58 plus prednisone prednisolone 58 Secondary endpoints included 58 MiStent DES 58 ARIKACE ™ 58 ARCOXIA 58 Factor VIIa 58 FOLFOX6 chemotherapy regimen 58 ANAVEX #-# [001] 58 guanfacine 58 Pharmacokinetic PK 58 CYP#A# substrate 58 hsCRP levels 58 CONCERTA ® 58 rBChE 58 Ventavis ® 58 cilengitide 58 sulodexide 58 voriconazole 58 zafirlukast 58 olanzapine Zyprexa 58 adrenoceptor agonist 58 PRTX 58 dyskinesia PD LID 58 FUSILEV enhances 58 eliglustat tartrate 58 ZOMIG 58 preclinical pharmacokinetic 58 vivo efficacy 58 etanercept Enbrel 58 elotuzumab 58 pegnivacogin 58 antiandrogens 58 metformin sulfonylurea 58 orally bioavailable 58 prokinetic agent 58 #.#mL 58 p# inhibitors 58 urinary N telopeptide 58 intravascular hemolysis 58 iniparib 58 ACUROX ® 58 VIAject R 58 ATL# [002] 58 BrachySil TM 58 selective agonist 58 ACCORD Lipid 58 antisense compounds 58 oxybutynin gel 58 Sanofi Lovenox 58 Androgel R 58 phase Ib 58 radiolabeled 58 ciclesonide 58 TYGACIL 58 angiotensin receptor blocker ARB 58 serum phosphorous 58 Tekamlo 58 gemcitabine Gemzar ® 58 equi analgesic doses 58 RAPAFLO R 58 Tarvacin TM 58 ISTODAX 58 Itraconazole 58 SILENOR 58 paclitaxel poliglumex 58 icatibant 58 NNRTI resistant virus 58 CDK inhibitor 58 FASLODEX 58 TRV# [001] 58 cytotoxicity 58 FK# 58 pegfilgrastim 58 dosing 58 lispro 58 Pioglitazone 58 DuraSite 58 ascending dose 58 azacytidine 58 VNP#M 58 Phase Ib clinical 58 HMG CoA reductase inhibitor 58 EQUETRO 58 allergic airway inflammation 58 unresectable HCC 58 phase IIa clinical 58 TLR agonists 58 Exforge HCT 58 MoxDuo TM IR 58 heparins 58 bendamustine 58 radiation sensitizer 58 Phase Ib study 58 Effexor venlafaxine 58 talabostat 58 thorough QT 58 pathophysiological effects 58 Zavesca R 58 antiangiogenic therapy 58 pegylated interferons 58 Phase 1a clinical 58 Perforomist TM Inhalation Solution 58 orally administered 58 epoetin beta 58 fibrotic disease 58 MabCampath 58 mitomycin 58 rosuvastatin #mg 58 Silodosin 58 adalimumab Humira 58 antifibrotic 58 IIIa inhibitor 58 OMNARIS HFA 58 Glatiramer acetate 58 potent antitumor activity 58 Vicinium TM 58 Candesartan 58 oral levofloxacin 58 Aurexis 58 mesalazine 58 BrachySil 58 antiangiogenic agent 58 XOPENEX 58 KRN# 58 EVIZON 58 CINOD 58 nitrofurantoin 58 ACE inhibitor ramipril 58 dose cohort 58 carboplatin paclitaxel 58 oral chemotherapeutic agent 58 Telintra 58 XL# SAR# 58 Telmisartan 58 dalbavancin 58 limiting toxicity DLT 58 metformin HCl 58 endoscopic gastric ulcers 58 GSK# [002] 58 GLP toxicology studies 58 immunological responses 58 Onbrez Breezhaler 58 ZD# [001] 58 Golimumab 58 PRIMO CABG 58 tumor necrosis 58 Gabapentin GR 58 R#/MEM # 58 canakinumab 58 D aspartate NMDA receptor 58 reslizumab 58 either acutely decompensated 58 mertansine 58 gabapentin Neurontin 58 lucinactant 58 hematological parameters 58 fluticasone salmeterol 58 tipifarnib 58 pegylated IFN 58 AZILECT ® 58 Cmax 58 OvaRex R 58 hyperphenylalaninemia HPA due 58 Nexavar sorafenib tablets 58 novel oral anticoagulant 58 Elacytarabine 58 ToGA 58 R baclofen 58 opioid induced bowel dysfunction 58 L lysine 58 morphometric vertebral fractures 58 neurologic progression 58 rituximab Rituxan 58 antineoplastic 58 LEXIVA 58 trials RCTs 58 PHX# 58 Triapine R 58 transdermal estradiol 58 XP# XP# 58 colesevelam 58 torsemide ER 58 TOLAMBA 58 Ticagrelor 58 paliperidone ER 58 Lofexidine 58 IMA# 58 PSMA ADC 58 conventional DMARDs 58 #ME# 58 VA# [002] 58 naltrexone hydrochloride 58 HuMax EGFr 58 atorvastatin #mg 58 factor TNF 58 serotonin synthesis 58 preclinical xenograft models 58 DOXIL 58 oxybutynin 58 RSD# 58 nasopharyngitis headache 58 tamsulosin 58 VELCADE melphalan 58 Angiolix 58 antiresorptive 58 paroxetine sertraline 58 somatostatin analogues 58 BROVANA 58 Piperacillin Tazobactam 58 highly selective inhibitor 58 tiotropium 58 rizatriptan 58 methylnaltrexone 58 thymalfasin 58 ROZEREM TM 58 5-FU/LV 58 racemic 58 cardiac repolarization 58 conventional siRNA molecules 58 enfuvirtide